Dengue outbreak may hit parts of country following rains, warns NIH
Advisory urges authorities and public to take immediate preventive measures to curb mosquito breeding
ISLAMABAD: The National Institute of Health (NIH) issued a warning that Punjab, Balochistan, and northern Pakistan are at risk of a dengue outbreak following recent rainfall across the country.
The advisory urges authorities and the public to take immediate preventive measures to curb mosquito breeding.
According to the NIH advisory, dengue thrives in warm and humid conditions, making post-rainfall periods a high-risk for virus transmission.
The institute warned that Pakistan recorded 28,427 dengue cases in 2024, a significant increase from the previous year, and further infections could rise if precautions are not implemented.
Dengue symptoms include high fever, severe headaches, joint and muscle pain, skin rashes, and eye pain.
The NIH has advised people to use only paracetamol for fever management while avoiding aspirin and NSAIDs, as they increase the risk of bleeding.
Severe dengue cases, particularly when platelet counts drop below 10,000, require immediate hospitalisation, the advisory added.
The NIH has urged people to take strict mosquito control measures, including:
- Using mosquito nets and repellents
- Wearing full-sleeved clothing
- Eliminating stagnant water to prevent mosquito breeding
Hospitals have also been directed to enhance laboratory facilities for dengue diagnosis. The NIH has stressed the need for public cooperation and timely medical consultation to prevent severe cases and fatalities.
-
Gene mutation may affect how schizophrenia patients see reality
-
Is all chocolate healthy? Here’s what the science really says
-
What to know before using weight-loss drugs like Ozempic
-
Singapore confirms first local spread of mutated monkeypox clade Ib strain
-
World Autism Awareness Day: Celebrating different minds, shaping a shared future
-
Some grief never goes away—Scientists now know why
-
E-cigarettes: A proving quitting tool that still carries health risks
-
Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine